Karriereverlauf von Marlies Sproll
Ehemalige bekannte Positionen von Marlies Sproll
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| MORPHOSYS AG | Technik-/Wissenschafts-/F&E-Leiter | 19.05.2010 | 15.04.2017 |
Lanthio Pharma BV
 Lanthio Pharma BV Medical SpecialtiesHealth Technology Lanthio Pharma BV focuses on discovering and developing lantipeptides for the generation of novel peptide therapeutics. Its product is a lanthionine-stabilized specific agonist of the AT2 receptor, which has great potential in diseases where tissue protection is important, like fibrosis. The company was founded in 2010 and is headquartered in Groningen, the Netherlands. | Direktor/Vorstandsmitglied | - | - |
Ausbildung von Marlies Sproll
| Max Planck Institute for Metals Research | Doctorate Degree |
Statistik
International
| Deutschland | 3 |
| Niederlande | 2 |
Operativ
| Chief Tech/Sci/R&D Officer | 1 |
| Doctorate Degree | 1 |
| Director/Board Member | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| MORPHOSYS AG | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Lanthio Pharma BV
Lanthio Pharma BV Medical SpecialtiesHealth Technology Lanthio Pharma BV focuses on discovering and developing lantipeptides for the generation of novel peptide therapeutics. Its product is a lanthionine-stabilized specific agonist of the AT2 receptor, which has great potential in diseases where tissue protection is important, like fibrosis. The company was founded in 2010 and is headquartered in Groningen, the Netherlands. | Health Technology |
- Börse
- Insiders
- Marlies Sproll
- Erfahrung
